Quote | StageZero Life Sciences Ltd (OTCMKTS:SZLSF)
Last: | $0.0015 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0015 |
Close: | $0.0015 |
High: | $0.0015 |
Low: | $0.0015 |
Volume: | 3,000 |
Last Trade Date Time: | 06/26/2024 03:00:00 am |
News | StageZero Life Sciences Ltd (OTCMKTS:SZLSF)
TORONTO, ON / ACCESSWIRE / May 23, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) (" StageZero " or the " Company "), an integrated healthcare company with the first and only mRNA multi-cancer diagnostic for screening for multiple, key cancers from a single sample of blood - Aris...
2024-05-21 10:39:08 ET StageZero Life Sciences Ltd. (SZLSF) Q1 2024 Results Conference Call May 21, 2024 08:00 AM ET Company Participants Rebecca Greco - Head Investor Relations James Howard Tripp - Chairman & Chief Executive Officer Presentation Op...
Message Board Posts | StageZero Life Sciences Ltd (OTCMKTS:SZLSF)
Subject | By | Source | When |
---|---|---|---|
$SZLSF StageZero Life Sciences Completes Acquisition of the | AskMuncher | investorshub | 09/07/2021 1:32:42 AM |
$SZLSF StageZero Life Sciences Completes Acquisition of the | AskMuncher | investorshub | 09/05/2021 2:38:38 PM |
GNWSF changed to SZLSF: | Renee | investorshub | 07/07/2021 9:59:36 PM |
GNWSF: effective Sept. 18,2020 a one for 8 | Renee | investorshub | 09/17/2020 1:06:39 PM |
GeneNews Limited changed to Stagezero Life Sciences Ltd. | Renee | investorshub | 06/27/2019 8:28:32 PM |
News, Short Squeeze, Breakout and More Instantly...
StageZero Life Sciences Ltd Company Name:
SZLSF Stock Symbol:
OTCMKTS Market:
TORONTO, ON / ACCESSWIRE / May 23, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) (" StageZero " or the " Company "), an integrated healthcare company with the first and only mRNA multi-cancer diagnostic for screening for multiple, key cancers from a single sample of blood - Aris...
TORONTO, ON / ACCESSWIRE / May 17, 2024 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS), an integrated healthcare company with the first and only mRNA multi-cancer diagnostic for screening for multiple, key cancers from a single sample of blood - Aristotle, and an oncologist-...
TORONTO, ON / ACCESSWIRE / April 5, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) (" StageZero " or the " Company "), an integrated healthcare company with the first and only mRNA multi-cancer diagnostic for screening for multiple, key cancers from a single sample of blood - Ari...